Alessa Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 8.76 M
About Alessa Healthcare
Alessa Healthcare Private Limited (AHPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 August 2019 (Five years and six months 28 days old ). Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹8.76 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Bhushankumar Sakharwade and Snehal Sakharwade serve as directors at the Company.
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100MH2019PTC328795
- Company No.
328795
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Aug 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Alessa Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhushankumar Sakharwade  | Director | 01-Aug-2019 | Current |
| Snehal Sakharwade | Director | 01-Aug-2019 | Current |
Financial Performance of Alessa Healthcare.
Alessa Healthcare Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Alessa Healthcare?
Unlock access to Alessa Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0
₹8.76 M
Charges Breakdown by Lending Institutions
- Others : 0.49 Cr
- Canara Bank : 0.39 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2022 | Others | ₹4.90 M | Satisfied |
| 09 Jan 2022 | Canara Bank | ₹0.28 M | Satisfied |
| 10 Jul 2020 | Canara Bank | ₹0.38 M | Satisfied |
| 04 Jul 2020 | Canara Bank | ₹3.00 M | Satisfied |
| 24 Apr 2020 | Canara Bank | ₹0.20 M | Satisfied |
How Many Employees Work at Alessa Healthcare?
Unlock and access historical data on people associated with Alessa Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alessa Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alessa Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.